Differential effects of μ-, δ- and κ-opioid receptor agonists on the discriminative stimulus properties of cocaine in rats

European Journal of Pharmacology

Volumn 324, Issue 1, 1997, Pages 21-29

  Suzuki, Tsutomu ^a   Mori, Tomohisa ^a   Tsuji, Minoru ^a   Maeda, Jun ^a   Kishimoto, Yayoi ^a   Misawa, Miwa ^a   Nagase, Hiroshi ^b  

^a HOSHI UNIVERSITY   (Japan)

^b TORAY INDUSTRIES INC   (Japan)

Author keywords

Cocaine; Drug discrimination; Drug interaction; Opioid

Indexed keywords

1,2,3,4,4A,5,12,12AALPHA OCTAHYDRO 4AALPHA (3 HYDROXYPHENYL) 2 METHYLQUINOLINO[2,3 G]ISOQUINOLINE; 3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; BETA FUNALTREXAMINE; COCAINE; DELTA OPIATE RECEPTOR AGONIST; DELTORPHIN; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; ISOQUINOLINE DERIVATIVE; KAPPA OPIATE RECEPTOR AGONIST; MORPHINE; MU OPIATE RECEPTOR AGONIST; NALTRIBEN; NALTRINDOLE; NORBINALTORPHIMINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DISCRIMINATIVE STIMULUS; DRUG DISCRIMINATION; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

3,4-DICHLORO-N-METHYL-N-(2-(1-PYRROLIDINYL)-CYCLOHEXYL)-BENZENEACETAMIDE, (TRANS)-ISOMER; ANALGESICS; ANALYSIS OF VARIANCE; ANIMALS; COCAINE; DISCRIMINATION (PSYCHOLOGY); DISCRIMINATION LEARNING; DOSE-RESPONSE RELATIONSHIP, DRUG; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; ENKEPHALIN, D-PENICILLAMINE (2,5)-; ENKEPHALINS; INJECTIONS, INTRAVENTRICULAR; MALE; MORPHINE; NARCOTICS; PYRROLIDINES; QUINOLINES; RATS; RATS, INBRED F344; RECEPTORS, OPIOID, DELTA; RECEPTORS, OPIOID, KAPPA; RECEPTORS, OPIOID, MU; SUBSTANCE-RELATED DISORDERS;

EID: 0031564627     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)00062-9     Document Type: Article

References (56)

1. 1 receptors in the nucleus accumbens, Psychopharmacology 115, 110.
2. Chavkin, C. and A. Goldstein, 1981, Specific receptor for the opioid peptide dynorphin: structure-activity relationship, Proc. Natl. Acad. Sci. USA 78, 6543.
3. Churchill, L. and P.W. Kalivas, 1992, Dopamine depletion produces augmented behavioral responses to a mu, but not a delta-opioid agonist in the nucleus accumbens: lack of role for receptor upregulation, Synapse 11, 47.
4. 1 and δ opioid receptors, Psychopharmacology 120, 347.
5. Cunningham, K.A., S.I. Dworkin and J.E. Smith, 1992, Neurobiology of cocaine: reinforcing and stimulus effects, in: Cocaine: Pharmacology, Physiology, and Clinical Strategies, eds. J.M. Lakoski, M.P. Galloway and F.J. White (CRC Press, London) p. 91.
6. Di Chiara, G. and A. Imperato, 1988, Drugs abused by humans preferentially increase synaptic dopamine concentration in the mesolimbic system of freely moving rats, Proc. Natl. Acad. Sci. USA 85, 5274.
7. Druhan, J.P., S.-E. Deschamps and J. Stewart, 1993, D-Amphetamine-like stimulus properties are produced by morphine injection into the ventral tegmental area but not into the nucleus accumbens, Behav. Brain Res. 59, 41.
8. Dworkin, S.I. and C. Bimle, 1989, 6-Hydroxydopamine lesions of the nucleus accumbens attenuate the discriminative stimulus effects of d-amphetamine, Drug Dev. Res. 16, 435.
9. Evans, S.M. and C.-E. Johanson, 1987, Amphetamine-like effects of anorectics and related compounds in pigeons, J. Pharmacol. Exp. Ther. 241, 817.
10. Funada, M., T. Suzuki, M. Narita, M. Misawa and H. Nagase, 1993, Blockade of morphine-reward through the activation of κ-opioid receptors in mice, Neuropharmacology 12, 1315.
11. Goeders, N.E., J.D. Lane and J.E. Smith, 1984, Self-administration of methionine enkephalin into the nucleus accumbens, Pharmacol. Biochem. Behav. 20, 451.
12. 3H]dopamine in rat brain tissue slices, Biochem. Pharmacol. 24, 847.
13. Jaffe, J.H., 1990, Drug addiction and drug abuse, in: The Pharmacological Basis of Therapeutics, eds. A.G. Gilman, T.W. Rall, A.S. Nies and P. Taylor (Pergamon Press, New York, NY) p. 522.
14. Jarbe, T.U.C., 1981, Cocaine cue in pigeons: time course studies and generalization to structurally related compounds (norcocaine, WIN 35,428 and 35,065-2) and (+)-amphetamine, Br. J. Pharmacol. 73, 843.
15. Jarbe, T.U.C., 1982, Discriminative stimulus properties of d-amphetamine in pigeons, Pharmacol. Biochem. Behav. 17, 671.
16. 6]enkephalin and naltrindole 5′-isothiocyanate: evidence for delta receptor subtypes, J. Pharmacol. Exp. Ther. 257, 1069.
17. Johnson, P.I. and J.R. Stellar, 1994, Comparison of delta opiate receptor agonist induced reward and motor effects between the ventral pallidum and dorsal striatum, Neuropharmacology 33, 1171.
18. Kalivas, P.W., E. Widerlov, D. Stanley, G. Breese and A.J. Prange Jr., 1983, Enkephalin action on the mesolimbic system: a dopamine-dependent and a dopamine-independent increase in locomotor activity, J. Pharmacol. Exp. Ther. 227, 229.
19. Kamei, J., A. Saitoh, M. Ohsawa, T. Suzuki, M. Misawa, H. Nagase and Y. Kasuya, 1995, Antinociceptive effects of the selective non-peptidic δ-opioid receptor agonist TAN-67 in diabetic mice, Eur. J. Pharmacol. 276, 131.
20. Koe, B.K., 1976, Molecular geometry of inhibitors of the uptake of catecholamines and serotonin in synaptosomal preparations of rat brain, J. Pharmacol. Exp. Ther. 199, 649.
21. Kosten, T.R., F.H. Gawin, B.J. Rounsaville and J.D. Klever, 1986, Cocaine abuse among opioid addicts: demographic factors in treatment, Am. J. Drug Alcohol Abuse 12, 1.
22. Kreek, M.J., 1987, Multiple drug abuse patterns and medical consequences, in: Psychopharmacology: The Third Generation of Progress, ed. H.Y. Meltzer (Raven Press, New York, NY) p. 1597.
23. 1-dependent stereotypies and stimulation of dopamine release in the nucleus accumbens, J. Neurosci. 11, 1565.
24. Lord, J.A.H., A.A. Waterfield, J. Hughes and H.W. Kosterlitz, 1977, Endogenous opioid peptides: multiple agonists and receptors, Nature 267, 495.
25. Martin, W.R., C.G. Eades, J.A. Thompson, R.E. Huppler and P.E. Gilbert, 1976, The effects of morphine- and nalorphine-like drugs in the nondependent and morphine-dependent chronic dogs, J. Pharmacol. Exp. Ther. 197, 517.
26. Masukawa, Y., T. Suzuki and M. Misawa, 1993, Differential modification of the rewarding effects of methamphetamine and cocaine by opioids and antihistamines, Psychopharmacology 111, 139.
27. 2]deltorphin II in mice: evidence for delta receptor subtypes, J. Pharmacol. Exp. Ther. 258, 583.
28. Menkens, K., E.J. Bilsky, K.D. Wild, P.S. Portoghese, L.D. Reid and F. Porreca, 1992, Cocaine place preference is blocked by the δ-opioid receptor antagonist, naltrindole, Eur. J. Pharmacol. 219, 345.
29. Meyer, M.E. and M.E. Meyer, 1993, Behavioral effects of opioid peptide agonists DAMGO, DPDPE, and DAKLI on locomotor activities, Pharmacol. Biochem. Behav. 45, 315.
30. Nagase, H., H. Wakita, K. Kawai, T. Endoh, H. Matsuura, C. Tanaka and Y. Takezawa, 1994, Syntheses of non-peptidic delta opioid agonists and their structure activity relationship, Jpn. J. Pharmacol. Suppl. I 64, 35P.
31. Narita, M., Y. Takahashi, K. Takamori, M. Funada, T. Suzuki, M. Misawa and H. Nagase, 1993a, Effects of κ-agonist on the antinociception and locomotor enhancing action induced by morphine in mice, Jpn. J. Pharmacol. 62, 15.
32. Narita, M., T. Suzuki, M. Misawa and H. Nagase, 1993b, Antagonism of the morphine-induced Straub tail reaction by κ-opioid receptor activation in mice, Psychopharmacology 110, 254.
33. Negus, S.T., N.K. Mello, P.S. Portoghese, S.E. Lukas and J.H. Mendelson, 1995, Role of delta opioid receptors in the reinforcing and discriminative stimulus effects of cocaine in rhesus monkeys, J. Pharmacol. Exp. Ther. 273, 1245.
34. Paxinos, G. and C. Watson, 1986, The Rat Brain in Stereotaxic Coordinates, 2nd edn. (Academic Press, Tokyo).
35. Pert, A. and C. Sivit, 1977, Neuroanatomical focus for morphine and enkephalin-induced hypermotility, Nature 265, 645.
36. Schechter, M.D., 1978, Lack of blockade of central dopaminergic receptors by narcotics: comparison with chlorpromazine, Eur. J. Pharmacol. 49, 279.
37. Schuster, C.R. and C.E. Johanson, 1988, Relationship between the discriminative stimulus properties and subjective effects of drugs, in: Psychopharmacology, Series 4: Transduction Mechanisms of Drug Stimuli, eds. F.C. Colpaert and R.L. Balster (Springer, Berlin) p. 161.
38. 5-Enkephalin generalizes to a discriminative stimulus produced by fentanyl but not ethylketocyclazocine, Pharmacol. Biochem. Behav. 16, 249.
39. Spanagel, R., A. Herz and T.S. Shippenberg, 1990, The effects of opioid peptides on dopamine release in the nucleus accumbens: an in vivo microdialysis study, J. Neurochem. 55, 1734.
40. Spealman, L.D. and J. Bergman, 1992, Modulation of the discriminative stimulus effects of cocaine by mu and kappa opioids, J. Pharmacol. Exp. Ther. 261, 607.
41. Spealman, L.D. and J. Bergman, 1994, Opioid modulation of the discriminative stimulus effects of cocaine: comparison of μ, κ and δ agonists in squirrel monkeys discriminating low doses of cocaine, Behav. Pharmacol. 5, 21.
42. Suzuki, T., M. Funada, M. Narita, M. Misawa and H. Nagase, 1991, Pertussis toxin abolishes μ- and δ-opioid agonist-induced place preference, Eur. J. Pharmacol. 205, 85.
43. Suzuki, T., Y. Shiozaki, T. Masukawa, M. Misawa and H. Nagase, 1992, The role of mu- and kappa-opioid receptors in cocaine-induced conditioned place preference, Jpn. J. Pharmacol. 58, 435.
44. Suzuki, T., M. Yoshiike, H. Mizoguchi, J. Kamei, M. Misawa and H. Nagase, 1994a, Blockade of δ-opioid receptors prevents morphine-induced place preference in mice, Jpn. J. Pharmacol. 66, 131.
45. Suzuki, T., T. Mori, M. Funada, M. Misawa and H. Nagase, 1994b, Attenuation of the discriminative stimulus properties of cocaine by δ-opioid receptor antagonists, Eur. J. Pharmacol. 263, 207.
46. Suzuki, T., T. Mori, M. Tsuji, M. Misawa and H. Nagase, 1994c, The role of δ-opioid receptor subtypes in cocaine- and methamphetamine-induced place preferences, Life Sci. 55, PL339.
47. Suzuki, T., T. Mori, M. Tsuji and M. Misawa, 1995a, Interaction between discriminative stimulus effects of cocaine and morphine, Jpn. J. Pharmacol. 67, 341.
48. Suzuki, T., M. Tsuji, T. Mori, M. Misawa and H. Nagase, 1995b, Effects of a highly selective nonpeptide δ opioid receptor agonist, TAN-67, on morphine-induced antinociception in mice, Life Sci. 57, 155.
49. 2 opioid receptor agonists in mice, Psychopharmacology 124, 211.
50. Suzuki, T., M. Tsuji, T. Mori, M. Misawa, T. Endoh and H. Nagase, 1996b, Effect of the highly selective and nonpeptide δ opioid receptor agonist TAN-67 on the morphine-induced place preference in mice, J. Pharmacol. Exp. Ther. 279, 177.
51. Suzuki, T., M. Tsuji, T. Mori, H. Ikeda, M. Misawa and H. Nagase, 1997, Involvement of dopamine-dependent and -independent mechanisms in the rewarding effects mediated by δ opioid receptor subtypes in mice, Brain Res. 744, 327.
52. Ukai, M., T. Kamiya, T. Toyoshi and T. Kameyama, 1992, Systemic administration of dynorphin A(1-13) markedly inhibits different behavioral responses induced by cocaine in the mouse, Neuropharmacology 31, 843.
53. 5]enkephalin, in the rat, Eur. J. Pharmacol. 231, 143.
54. Ukai, M., M. Mizutani and T. Kameyama, 1994, Opioid peptides selective for receptor types modulate cocaine-induced behavioral responses in mice, Jpn. J. Psychopharmacol. 14, 153.
55. 4]deltorphin with δ-opioid receptor subtypes in vivo, Eur. J. Pharmacol. 252, 133.
56. Wood, D.M. and M.W. Emmett-Oglesby, 1989, Mediation of nucleus accumbens of the discriminative stimulus produced by cocaine, Pharmacol. Biochem. Behav. 33, 453.